Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Shire reports positive phase II results for Lambda

June 30, 1999

FDA approves 15-mg Ditropan XL tablets

June 30, 1999

Zeria designs dual-action arylpiperazines for BPH

June 28, 1999

WAY-133537: safe and effective agent for bladder instability

June 28, 1999

Merck describes new selective alpha1a-adrenoceptor blockers and use in BPH

June 21, 1999

Dutasteride suppresses DHT levels more effectively, consistently than finasteride

June 21, 1999

Substantially pure (S)-(+)-enantiomer form of ETA antagonist prepared at Pfizer

June 15, 1999

Imidazotriazinones synthesized at Bayer inhibit cGMP-PDE isozymes

June 14, 1999

Tricyclic cGMP-PDE inhibitors for urinary incontinence and related disorders

June 8, 1999

New compounds from SS Pharm. with greater bladder selectivity than oxybutynin

June 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...